Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA syndrome) in commercial sheep

[1]  Deming Zhao,et al.  The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation , 2012, Journal of Neuroinflammation.

[2]  Jicheng Li,et al.  Progress of Research in Cell‐in‐Cell Phenomena , 2012, Anatomical record.

[3]  E. Israeli Gulf War Syndrome as a part of the autoimmune (autoinflammatory) syndrome induced by adjuvant (ASIA) , 2012, Lupus.

[4]  R. Gherardi,et al.  Macrophagic myofasciitis: characterization and pathophysiology , 2012, Lupus.

[5]  C. Shaw,et al.  Aluminum vaccine adjuvants: are they safe? , 2011, Current medicinal chemistry.

[6]  Y. Shoenfeld,et al.  'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. , 2011, Journal of autoimmunity.

[7]  J. A. García de Jalón,et al.  Possible adverse reactions in sheep after vaccination with inactivated BTV vaccines , 2010, Veterinary Record.

[8]  Christopher Exley,et al.  The immunobiology of aluminium adjuvants: how do they really work? , 2010, Trends in immunology.

[9]  R. Koike,et al.  Cryopyrin-associated periodic syndromes: background and therapeutics , 2010, Modern rheumatology.

[10]  P. Brugières,et al.  Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction. , 2009, Journal of inorganic biochemistry.

[11]  M. S. Petrik,et al.  Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration. , 2009, Journal of inorganic biochemistry.

[12]  Vijay Kumar,et al.  Aluminium neurotoxicity: neurobehavioural and oxidative aspects , 2009, Archives of Toxicology.

[13]  P. Marrack,et al.  Towards an understanding of the adjuvant action of aluminium , 2009, Nature Reviews Immunology.

[14]  Christopher Exley,et al.  A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. , 2009, Medical hypotheses.

[15]  D. Cordato,et al.  Post-vaccination encephalomyelitis: Literature review and illustrative case , 2008, Journal of Clinical Neuroscience.

[16]  Richard A. Flavell,et al.  Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants , 2008, Nature.

[17]  G. Trendelenburg Acute Neurodegeneration and the Inflammasome: Central Processor for Danger Signals and the Inflammatory Response? , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  W. Egan,et al.  Corrigendum to “Aluminum salts in vaccines—US perspective” [Vaccine 20 (Suppl. 2) (2002) S18–S23] , 2002 .

[19]  Paul Richman,et al.  Aluminum salts in vaccines--US perspective. , 2002, Vaccine.

[20]  F. Authier,et al.  Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. , 2001, Brain : a journal of neurology.

[21]  J. Cummings,et al.  Equine motor neuron disease. , 1997, The Veterinary record.

[22]  M. Ehrenfeld,et al.  A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants. , 1999, The Journal of rheumatology.